文献速递颈动脉与弓上血管

症状性颈动脉疾病早期血运重建(3-14天)带来更优结局:10年多中心队列分析

Early revascularization in symptomatic carotid artery disease leads to better outcomes: A 10-year multicenter cohort analysis.
PubMed 文献 · J Vasc Surg · 2026-09-21

该回顾性多中心队列纳入2016-2026年821例症状性颈动脉疾病血运重建手术,按症状至干预时间分为紧急(0-2天)、早期(3-14天)和延迟(≥15天)组。紧急时机和未术前抗血栓治疗是30天复合终点的独立预测因子。结论支持3-14天窗口为症状性患者的最佳血运重建策略。

要点

  • 症状后3-14天行颈动脉血运重建的30天复合终点最低(2.8%)。
  • 紧急(0-2天)血运重建30天死亡率(2.9%)和再干预风险(HR 4.13)显著更高。
  • 延迟(≥15天)干预再干预风险最高(HR 5.63),早期组3年免再干预生存率达97.9%。

核心结论

  • 症状性颈动脉疾病在神经血管症状后3-14天行血运重建,围术期和长期结局最优。
  • 紧急血运重建围术期风险显著更高,延迟超过14天则再干预率更高。

研究设计与样本

  • 回顾性多中心队列分析,纳入2016-2026年821例颈动脉血运重建手术,排除既往颈部放疗者。
  • 按症状至干预时间分为紧急(0-2天)、早期(3-14天)和延迟(≥15天)组。
  • 中位年龄74.2岁(IQR 66.7-80.5),男性69.4%,高血压86.1%,高脂血症84.4%,冠心病35.6%。
  • 最常见表现为卒中(48.4%),其次TIA(31.8%)和一过性黑矇(19.9%)。

关键数值与推荐

  • 推荐考虑将症状后3-14天作为症状性颈动脉疾病血运重建的最佳时间窗。
  • 紧急(0-2天)血运重建与更高的30天复合终点(8.0% vs 2.8%)和再干预风险(HR 4.13)相关。

临床怎么用

  • 对症状性颈动脉疾病患者,应优先安排在症状后3-14天窗口内进行血运重建。
  • 避免不必要的紧急(0-2天)干预,因其围术期死亡和再干预风险更高。
  • 不应将干预延迟至14天以后,否则再干预风险显著增加。
  • 术前应确保患者接受抗血栓治疗,以降低30天复合终点风险。

局限性

  • 回顾性研究设计,存在选择偏倚和混杂因素可能。
  • 未报告具体多中心数量及各级医院分布。
  • 长期心梗亚组分析仅限于初始TIA患者,样本量可能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Randomized trials and meta-analyses have suggested that earlier intervention for symptomatic carotid artery disease may benefit patients, yet the optimal timing window remains debated. This study evaluated the impact of timing of revascularization on perioperative and long-term outcomes. METHODS: We conducted a retrospective review of 821 carotid revascularization procedures for carotid artery disease from 2016 to 2026, excluding patients with previous neck radiation. Procedures were stratified by time from symptom onset to intervention into urgent (0-2 days), early (3-14 days), and delayed (≥15 days) groups. Perioperative end points included 30-day mortality, ipsilateral stroke, transient ischemic attack (TIA), myocardial infarction (MI), and a composite of these events. Long-term outcome end points included all-cause mortality, ipsilateral stroke, TIA, MI, restenosis, and reintervention. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify independent predictors of the 30-day composite outcome and long-term reintervention. Sensitivity analyses were also included excluding patients who underwent thrombolysis or thrombectomy to adjust for factors related to adjunct procedures at the time of initial neurovascular event presentation. RESULTS: The study cohort had a median age of 74.2 years (interquartile range, 66.7-80.5) and was predominantly composed of male patients (69.4%), with high rates of hypertension (86.1%), hyperlipidemia (84.4%), and coronary artery disease (35.6%). The most common presentation was stroke (48.4%), followed by TIA (31.8%) and amaurosis fugax (19.9%). The 30-day composite outcome of stroke, TIA, MI, or death was significantly lower in the early group (2.8%) than in the delayed (4.0%) and urgent (8.0%) groups (P = .03). Thirty-day mortality was significantly higher in the urgent group (2.9%) than in the early (0.3%) and delayed (0.3%) groups (P = .01). On multivariable Cox regression, urgent timing [hazard ratio (HR), 2.50; 95% confidence interval, 1.02-6.12; P = .044] and absence of preoperative antithrombotic therapy (HR, 3.75; 95% confidence interval, 1.46-9.64; P = .006) were independent predictors of the 30-day composite outcome. At a median follow-up of 2.8 years (interquartile range, 1.1-5.3), all-cause mortality was comparable across groups (urgent, 20.4% vs early, 18.5% vs delayed, 16.5%; P = .57). Long-term MI was more frequent in the early group (4.7%) than in the urgent (1.5%) and delayed (1.6%) groups (P = .03), confined entirely to those initially presenting with TIA on subgroup analysis. Long-term restenosis was highest in the urgent group (9.5%), followed by delayed (5.3%) and early groups (3.9%; P = .05). Reintervention rates followed the same pattern (urgent, 6.6% vs delayed, 3.1% vs early, 1.1%; P < .01), with a 3-year reintervention-free survival of 97.9% for early, 76.3% for urgent, and 74.6% for delayed (log-rank P = .009). On multivariable Cox regression, both urgent (HR, 4.13; P = .018) and delayed (HR, 5.63; P = .003) timing were independently associated with higher reintervention risk compared with early revascularization. In both sensitivity analysis excluding patients who underwent thrombolysis and thrombectomy, 30-day composite outcomes remained significantly higher for the urgent group, as did restenosis and reinterventions outcomes. CONCLUSIONS: Early carotid revascularization between 3 and 14 days after neurovascular symptoms have most favorable perioperative and long-term outcomes compared with both urgent and delayed intervention. Urgent revascularization carries significantly higher perioperative risk, whereas delayed intervention beyond 14 days reduces the potential preventive benefit of timely revascularization and is associated with higher long-term reintervention rates. These findings support consideration of revascularization within a 3- to 14-day window as the optimal strategy for symptomatic patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sanchez-Calderin D, Meschia JF, Kumar G, et al. Early revascularization in symptomatic carotid artery disease leads to better outcomes: A 10-year multicenter cohort analysis. J Vasc Surg. 2026. PMID: 42767435. doi:10.1016/j.jvs.2026.07.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。